COVID-19 Research
The Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes the COVID-19 respiratory disease. SARS-CoV-2 is highly contagious and transmits predominantly via the respiratory route. It is an enveloped virus with a single-stranded RNA genome. Small molecules can be used to investigate the virus and the corresponding immune response. Researchers can save up to 50% on high purity Covid-19 research products - they are up to half the price of other suppliers.
View products: Compound repurposing | Virus attachment / entry | Viral replication | Cytokine storm | Organoids | Cell culture reagents | Cell stains, viability & proliferation | CRISPR / gene editing
- Description:
Selective α-mannosidase I inhibitor
2,4-Diamino-6-hydroxypyrimidine (HB0070)
Description:GTP cyclohydrolase I (GCH1) inhibitor
Purity:>98%
-
5,7-Dichlorokynurenic acid (HB0078)
Description:Potent, selective, competitive glycine site NMDA receptor antagonist
Purity:>98%
-
-
Dihydrochlamydocin (HB3874)
Description:Phytotoxin. Derivative of the HDAC inhibitor chlamydocin.
Purity:>95%
-
Dihydroergocristine mesylate (HB1611)
Description:5-HT antagonist. Also partial agonist at adrenergic and dopaminergic receptors.
Purity:>98%
-
Dihydroergotamine mesylate (HB1612)
Description:Partial α-adrenergic agonist, partial D2 agonist and 5-HT antagonist
Purity:>98%
